Newbridge Announces Agreement For Distribution of Biogen Multiple Sclerosis Therapies in The Middle East and North Africa


NewBridge Pharmaceuticals (“NewBridge” or “the Company”) announce that they have entered a distribution agreement with Biogen International GmbH (Biogen) for the distribution and commercialization of certain Biogen Multiple Sclerosis products in selected countries in the Middle East and North Africa (“MENA”).